Image For Activity Cover
Thyroid Neoplasia and Cancer
Presentations/Presenters
Thyroid Neoplasia and Cancer
Presenter: Sayeepriyadarshini Anakk, PhD (University of Illinois)
No relevant financial relationships

Thyroid Neoplasia and Cancer
Presenter: Frank Claessens, PhD (KU Leuven)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Rodis Paparodis, MD (University of Toledo, Ohio, USA)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Nancy Salim, MS (University of Toledo, Ohio, USA)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Haider Sarwar, MD (University of Toledo, Ohio, USA)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Dr. Shahnawaz Imam, DVM, PhD (University of Toledo)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Shafiya Rafiqi, DVM, PhD (University of Toledo)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Sophia Ali, MBBS (university of Toledo)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: azra niaz, MD (UNIVERSITY OF TOLEDO)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Abed Kanzy, MD (UNIVERSITY OF TOLEDO)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Yara Tovar, MD (UNIVERSITY OF TOLEDO)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: MOHAMMED MADKHALI, MD (university of Toledo)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: ahmed Elsherif, MD (university of Toledo)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: feras khogeer, MD (university of Toledo)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: Zeeshan Zahid, MBBS (university of Toledo)
No relevant financial relationships

Decoding Cancer Immunoediting of Tumor Microenvironment Provides Immunogenomic Marker for Thyroid Cancer Screening
Presenter: JUAN JAUME, MD, PHD (university of Toledo)
No relevant financial relationships

The RCAN 1.4 Metastasis Progression Suppressor Gene is Hypermethylated at Intron 1 and Downregulated in Papillary Thyroid Cancer
Presenter: Dr. Tilak Khanal, PhD (The Ohio State University)
No relevant financial relationships

The RCAN 1.4 Metastasis Progression Suppressor Gene is Hypermethylated at Intron 1 and Downregulated in Papillary Thyroid Cancer
Presenter: Neel Rajan, BS (The Ohio State University)
No relevant financial relationships

The RCAN 1.4 Metastasis Progression Suppressor Gene is Hypermethylated at Intron 1 and Downregulated in Papillary Thyroid Cancer
Presenter: Wei Li, MD (The Ohio State University)
No relevant financial relationships

The RCAN 1.4 Metastasis Progression Suppressor Gene is Hypermethylated at Intron 1 and Downregulated in Papillary Thyroid Cancer
Presenter: Sandya Liyanarachchi, MS (The Ohio State University)
No relevant financial relationships

The RCAN 1.4 Metastasis Progression Suppressor Gene is Hypermethylated at Intron 1 and Downregulated in Papillary Thyroid Cancer
Presenter: Matthew Ringel, MD (The Ohio State University)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Ms. Karina C. Peres, MSc (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Mateus L. Bezerra, MD (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Alexandre H. B. Matos, PhD (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Larissa T. Rabi, MSc (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Alfio J. Tincani, MD PhD (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Priscila C. Tincani, MD PhD (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Icléia S. Barreto, MD PhD (São Leopoldo Mandic Faculty)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Leandro L. L. Freitas, MD PhD (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Lucas L. Cunha, MD PhD (Federal University of São Paulo)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Natassia E. Bufalo, PhD (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Murilo V. Geraldo, PhD (University of Campinas)
No relevant financial relationships

Identification of MicroRNAs Critical to the Lymph Node Metastatic Process of Thyroid Cancer
Presenter: Laura S. Ward, MD PhD (University of Campinas)
No relevant financial relationships

Integrins as Potential Molecular Targets in Thyroid Cancer Imaging and Therapy
Presenter: Joanna Klubo-Gwiezdzinska, MD, PhD (NIH)
No relevant financial relationships

Integrins as Potential Molecular Targets in Thyroid Cancer Imaging and Therapy
Presenter: Sonam Kumari, PhD (NIH)
No relevant financial relationships

Integrins as Potential Molecular Targets in Thyroid Cancer Imaging and Therapy
Presenter: Thakur Shilpa, PhD (NIH)
No relevant financial relationships

Integrins as Potential Molecular Targets in Thyroid Cancer Imaging and Therapy
Presenter: Vasyl Vasko, MD, PhD (USUHS)
No relevant financial relationships

Integrins as Potential Molecular Targets in Thyroid Cancer Imaging and Therapy
Presenter: Zhantong Wang, PhD (NIH)
No relevant financial relationships

mTOR Signaling is Associated with Regulation of Mitochondrial Respiration in Thyroid Cancer
Presenter: Dr. Sonam Kumari, Ph.D (National Institutes of Health)
No relevant financial relationships

mTOR Signaling is Associated with Regulation of Mitochondrial Respiration in Thyroid Cancer
Presenter: Shilpa Thakur, PhD (National Institutes of Health)
No relevant financial relationships

mTOR Signaling is Associated with Regulation of Mitochondrial Respiration in Thyroid Cancer
Presenter: Joanna Klubo-Gwiezdzinska, MD, PhD (National Institutes of Health)
No relevant financial relationships

Novel Murine Models of BrafV600E driven Papillary Thyroid Cancer
Presenter: Mrs. Grace Purvis, MS (Children's Hospital of Philadelphia)
No relevant financial relationships

Novel Murine Models of BrafV600E driven Papillary Thyroid Cancer
Presenter: Victoria Casado Medrano, PhD (Children's Hospital of Philadelphia)
No relevant financial relationships

Novel Murine Models of BrafV600E driven Papillary Thyroid Cancer
Presenter: Alison O'Neill, MD (Children's Hospital of Philadelphia)
No relevant financial relationships

Novel Murine Models of BrafV600E driven Papillary Thyroid Cancer
Presenter: Michele Scheerer, Ba (Children's Hospital of Philadelphia)
No relevant financial relationships

Novel Murine Models of BrafV600E driven Papillary Thyroid Cancer
Presenter: Zachary Spangler, Ba (Children's Hospital of Philadelphia)
No relevant financial relationships

Novel Murine Models of BrafV600E driven Papillary Thyroid Cancer
Presenter: Aime Franco, PhD (Children's Hospital of Philadelphia)
No relevant financial relationships
Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
1.5 AMA PRA Category 1 Credits
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By